Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clindamycin prophylaxis for prevention of infection and implant failure after dental implant placement
2017-002168-42Phase 4Active
- Sponsor
- Iciar Arteagoitia Calvo
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial in surgical site infection (SSI) and dental implant failure comparing Clindamycin hydrochloride with Placebo (2 arms). Primary endpoint: Incidence rate of postoperative infection and/or dental implant failure. Started Sep 2018; status: active.
02
Drugs
clindamycin
03
Conditions
surgical site infection (SSI)dental implant failure
Beyond the preview
Go deeper on 2017-002168-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002168-42.